A Metal‐Phenolic Nanocluster Orchestrates Mito‐Ca 2+ Metabolic Autonomy for Tumor Ca 2+ Interference Therapy
Advanced Science · 2026
DOI: 10.1002/advs.76243 ↗At a glance
Journal article in Advanced Science, 2026. Written by Ronglong Chen and 13 co-authors. Institution: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Y…. Major MEDLINE topics: Calcium, Calcium Channels, Mitochondria, Phenols. Cited 1 times so far (Crossref); 59 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research, Science and Technology Program of Guangdong.
Abstract (original language)
Mitochondrial Ca 2+ (mito‐Ca 2+ ) interference, an effective mitochondria destruction strategy in cancer treatment, suffers from precise self‐protective Ca 2+ metabolic autoregulation by Ca 2+ channels. Direct regulation of Ca 2+ channels‐mediated mito‐Ca 2 + metabolic autonomy will overcome this obstacle for advanced Ca 2+ interference therapy. Here, we engineer a novel meta‐phenolic nanocluster (TCMH) by self‐assembly of polyphenols encapsulating mitochondrial calcium uniporter (MCU) modulators (mitofusin 1 siRNA (siMFN1), H 2 S donor) and Ca 2+ via metal‐phenolic coordination. After cellular internalization, the acid‐responsive disassembly of TCMH triggers the release of its’ payloads. TCMH promotes a rapid surge in mito‐Ca 2+ via synergistic MCU activation by siMFN1‐mediated mitochondrial fusion suppression and released H 2 S. Furthermore, integrating with H 2 S‐mediated reactive oxygen species (ROS) enrichment, this Ca 2+ ‐based TCMH forms a self‐amplifying ROS‐Ca 2 + positive feedback loop to sensitize mitochondrial apoptosis. TCMH potently benefits robust antitumor therapeutics in both oral squamous cell carcinoma orthotopic and patient‐derived xenograft models. Together, a powerful MCU‐mediated mito‐Ca 2+ metabolic autonomy modulation tactic is highlighted here to optimize precise tumor Ca 2+ interference therapy.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Reproductive Medicine Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
- Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
- Nanhai Translational Innovation Center of Precision Immunology, Sun Yat-Sen Memorial Hospital, Foshan, China.
- Department of Oral and Maxillofacial Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Department of Musculoskeletal Oncology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
ORCID profiles: Zhiquan Huang
Funding
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research
- Science and Technology Program of Guangdong
- Guangzhou Science and Technology Project
Cite
APA
Chen, R., Huang, J., Wang, Y., Yao, S., Wu, F., Liu, J., Song, C., Lin, L., Lin, X., Deng, Y., Zhang, C., Huang, Z., Huang, Z., & Xie, L. (2026). A Metal‐Phenolic Nanocluster Orchestrates Mito‐Ca 2+ Metabolic Autonomy for Tumor Ca 2+ Interference Therapy. Advanced Science. https://doi.org/10.1002/advs.76243
Vancouver
Chen R, Huang J, Wang Y, Yao S, Wu F, Liu J, et al. A Metal‐Phenolic Nanocluster Orchestrates Mito‐Ca 2+ Metabolic Autonomy for Tumor Ca 2+ Interference Therapy. Advanced Science. 2026. doi:10.1002/advs.76243
BibTeX
@article{Chen2026,
author = {Chen, Ronglong and Huang, Jia and Wang, Yuepeng and Yao, Shucong and Wu, Fei and Liu, Juan and Song, Chunxue and Lin, Li and Lin, Xijun and Deng, Yingjie and Zhang, Chao and Huang, Zhiquan and Huang, Zixian and Xie, Lisi},
title = {A Metal‐Phenolic Nanocluster Orchestrates Mito‐Ca 2+ Metabolic Autonomy for Tumor Ca 2+ Interference Therapy},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76243}
}
EUVIMED